Commercial Weight Loss Programs in the Management of Obesity: an Update.

ABSTRACT:

Purpose of review

Comprehensive lifestyle programs are cornerstones of obesity management, but clinician referrals may be limited by program availability. Commercial weight loss programs may be an alternative, but clinicians may be unaware of their efficacy and safety. This review describes the evidence for commercial programs, particularly 12-month weight loss, among individuals with obesity.

Recent findings

Several programs are concordant with evidence-based recommendations (i.e., lower-calorie diet, increased physical activity, and behavioral strategies). Among the guideline-concordant programs, National Diabetes Prevention Program, WW, Jenny Craig, Medifast, and OPTIFAST have demonstrated 12-month weight loss efficacy and safety. While other programs show promise, more e

SUBMITTER: Laudenslager M 

PROVIDER: S-EPMC8159888 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature